Real‐world data: Assessing electronic health records and medical claims data to support regulatory decision‐making for drug and biological products

Cynthia J. Girman; Mary E. Ritchey; Vincent Lo Re

doi:10.1002/pds.5444

journal article Open Access May 03, 2022

Real‐world data: Assessing electronic health records and medical claims data to support regulatory decision‐making for drug and biological products

Cynthia J. Girman

Mary E. Ritchey

Vincent Lo Re

Pharmacoepidemiology and Drug Safety Vol. 31 No. 7 pp. 717-720 · Wiley

View at Publisher Save 10.1002/pds.5444

Topics

No keywords indexed for this article. Browse by subject →

References

15

[1]

U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER) and Oncology Center for Excellence (OCE). Real‐World Data: Assessing electronic health records and medical claims to support regulatory decision‐making for drug and biological products: Guidance for Industry Draft Guidance. Sept2021.https://www.fda.gov/regulatory‐information/search‐fda‐guidance‐documents/real‐world‐data‐assessing‐electronic‐health‐records‐and‐medical‐claims‐data‐support‐regulatory.

[2]

DanielG SilcoxC BryanJ McClellanM RomineM FrankK.Characterizing RWD quality and relevancy for regulatory purposes. Duke‐Margolis Center for Health Policy. Retrieved October 01 2018.https://healthpolicy.duke.edu/sites/default/files/atoms/files/characterizing_rwd.pdf.

[3]

10.1002/pdf.4697

[4]

10.1007/s43441‐020‐00139‐x

[5]

10.1007/s40264-019-00851-0

[6]

https://www.sentinelinitiative.org. Accessed Oct 3 2021.

[7]

10.1007/s43441‐020‐00252‐x

[8]

10.2217/cer.14.16

[9]

10.1007/978-0-387-87959-8

[10]

10.1007/s40471-014-0027-z

[11]

10.1016/j.cct.2016.09.003

[12]

10.1186/s12874‐021‐01285‐y

[13]

10.1002/cpt.1480

[14]

10.1002/cpt.23

[15]

10.1002/pds.2229

Metrics

41

Citations

15

References

Details

Published: May 03, 2022
Vol/Issue: 31(7)
Pages: 717-720
License: View

Authors

C

Cynthia J. Girman

Real World Evidence and Patient Outcomes, CERobs Consulting, LLC Wrightsville Beach North Carolina USA

M

Mary E. Ritchey

Real World Evidence and Patient Outcomes, CERobs Consulting, LLC Wrightsville Beach North Carolina USA; Med Tech Epi, LLC Philadelphia Pennsylvania USA; Center for Pharmacoepidemiology & Treatment Science Rutgers University New Brunswick New Jersey USA

V

Vincent Lo Re

Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA

Cite This Article

Cynthia J. Girman, Mary E. Ritchey, Vincent Lo Re (2022). Real‐world data: Assessing electronic health records and medical claims data to support regulatory decision‐making for drug and biological products. Pharmacoepidemiology and Drug Safety, 31(7), 717-720. https://doi.org/10.1002/pds.5444

Real‐world data: Assessing electronic health records and medical claims data to support regulatory decision‐making for drug and biological products

You May Also Like